CHICAGO--The SNP Consortium late last month released 2,279 newly identified single-nucleotide polymorphisms, mapped to their chromosomal locations, for public access. The markers are available through both the consortium's website at http://snp.cshl.org and the US National Center for Biotechnology Information SNP database at http://www.ncbi.nlm.nih.gov.
The consortium was formed earlier this year to identify 300,000 and map at least 150,000 SNPs from the human genome over a two-year period. Members are AstraZeneca, Bayer, Bristol-Myers Squibb, Hoffmann-La Roche, Glaxo Wellcome, Hoechst Marion Roussel, Motorola BioChip Systems, Novartis, Pfizer, Searle, SmithKline Beecham, and the Wellcome Trust. The Stanford Human Genome Center, Washington University School of Medicine, and the Whitehead Institute for Biomedical Research are performing SNP identification and mapping, and the Cold Spring Harbor Laboratory is managing bioinformatics for the project.